IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Yu Fan

Q1 2021 Holdings

Filed 2021-05-17 | 5 holdings | $18.5M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2021-09-17) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Atea Pharmaceuticals Inc(AVIR)COM04683R106$18.5M300,00099.9%
Pulmonx Corp(LUNG)COM745848101$13.9K303,0300.1%
ABG Acquisition Corp IACL A SHSG00496102$5.0K501,3000.0%
Aeglea Biotherapeutics Inc(AGLEUSD)COM00773J103$887112,0440.0%
Diffusion Pharmaceuticals inCOM PAR253748305$8289,8480.0%